Filter
13763
Filtered Results: 13763
Text search:
World
Health
Organzation
WHO
Featured
Recommendations
1250
New Publications
3172
Language
Document type
No document type
6996
Studies & Reports
2283
Guidelines
1705
Manuals
608
Fact sheets
585
Strategic & Response Plan
477
Training Material
268
Situation Updates
257
Infographics
157
Resource Platforms
147
Online Courses
116
Videos
87
Brochures
46
Dashboards/Maps
21
App
10
Countries / Regions
Global
683
India
423
Kenya
318
Sierra Leone
268
Nigeria
247
Ethiopia
237
Liberia
235
Uganda
229
Western and Central Europe
223
Nepal
213
South Africa
213
Latin America and the Carribbean
203
Africa
192
Syria
185
Russia
180
Myanmar / Burma
175
Ukraine
162
Rwanda
160
Bangladesh
160
Zambia
155
Congo, Democratic Republic of
150
Malawi
149
Tanzania
140
Ghana
135
Mozambique
120
Philippines
108
Eastern Europe
107
South Sudan
105
Indonesia
104
Brazil
104
Middle East and North Africa
103
West and Central Africa
92
Namibia
88
Yemen
86
South–East Asia Region
86
Haiti
84
Guinea
80
Lesotho
80
Senegal
79
Cambodia
79
Zimbabwe
78
East and Southern Africa
76
Asia
67
Venezuela
62
Germany
60
Burkina Faso
59
Colombia
54
Cameroon
52
Eastern Europe and Central Asia
51
Botswana
50
Angola
47
Eswatini/ Swaziland
40
Mali
39
Pakistan
38
Madagascar
38
Sudan
36
Benin
36
Paraguay
34
Afghanistan
33
China
33
Somalia
32
Central African Republic
32
Western Pacific Region
29
Vietnam
29
Jordan
28
Guinea-Bissau
27
Côte d’Ivoire / Ivory Coast
27
Lebanon
26
Thailand
25
Peru
24
Niger
23
Tajikistan
23
Argentina
21
Iraq
19
Chad
19
Turkey
18
Moldova
18
Sri Lanka
17
Laos
16
Ecuador
15
Chile
15
Albania
15
Georgia
14
Mexico
13
North America
13
USA
12
Palestine
12
Spain
12
Egypt
11
Bolivia
11
Armenia
11
Kyrgyzstan
11
Kazakhstan
11
Saudi Arabia
10
Libya
10
Southern Africa
10
Iran
10
Portugal
10
Belarus
10
Togo
9
Burundi
9
Greece
9
Papua New Guinea
8
North Macedonia
8
Timor Leste/ East Timor
8
Romania
8
Malaysia
7
Poland
7
Gambia
6
Serbia
6
El Salvador
6
Bhutan
6
Estonia
6
Jamaica
6
Japan
6
Tunisia
6
Morocco
5
Hungary
5
Honduras
5
Guatemala
5
Italy
5
Uzbekistan
5
Turkmenistan
5
France
5
Azerbaijan
5
Mauritania
4
Fiji
4
Djibouti
4
Congo-Brazzaville
4
United Kingdom
4
Singapore
3
Mongolia
3
Canada
3
Qatar
3
Gabon
3
Uruguay
3
Mauritius
3
Bosnia and Herzegovina
3
Vanuatu
2
Croatia
2
Cuba
2
Nicaragua
2
North Korea
2
Bulgaria
2
Lithuania
2
Slovakia
2
Denmark
2
Israel
2
Ireland
1
Dominican Republic
1
Switzerland
1
Cape Verde
1
Other region
1
Solomon Islands
1
Australia
1
Belgium
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
Morocco
1
Latvia
1
Barbados
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
4674
Clinical Guidelines
1013
Public Health
769
Women & Child Health
687
Key Resources
588
Capacity Building
302
Pharmacy & Technologies
144
Annual Report MEDBOX
2
Toolboxes
COVID-19
1663
Mental Health
1009
HIV
952
TB
739
Disability
564
Planetary Health
503
Rapid Response
483
NTDs
470
Ebola
451
AMR
398
Conflict
367
Caregiver
366
NCDs
358
Global Health Education
262
Refugee
225
Pharmacy
215
Natural Hazards
168
Zika
154
Health Financing Toolbox
141
Cholera
116
Polio
81
Specific Hazards
68
Social Ethics
53
Typhoon
8
Health Financing
3
South Sudan
2
BMC Medicine201210:107
https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012
Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012
In 2011, the World ... Organization’s (WHO) mental health Gap Action Programme (mhGAP) released evidence-based epilepsy-care guidelines for use in low and middle income countries (LAMICs). From a
geographical, sociocultural, and political perspective, LAMICs represent a heterogenous group with significant differences in the epidemiology, etiology, and perceptions of epilepsy. Successful implementation of
the guidelines requires local adaptation for use within individual countries. For effective implementation and sustainability, the sense of ownership and empowerment must be transferred from the global health authorities to the local people. Sociocultural and financial barriers that impede the implementation of the guidelines should be
identified and ameliorated. Impact assessment and program revisions should be planned and a budget allocated to them. If effectively implemented, as intended, at the primary-care level, the mhGAP
guidelines have the potential to facilitate a substantial reduction in the epilepsy treatment gap and improve the quality of epilepsy care in resource-limited settings.
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited a...
To provide a foundation for the strategic policy and programme development needed to ensure the sustainable implementation of effective interventions for reducing the global burden of PPH
This manual was developed based on the recommendations of a global technical consultation on child health in humanitarian emergencies co-organized by WHO and UNICEF at the end of 2003. ... in collaboration with the Centre for Refugee and Disaster Response, Bloomberg School of Public Health, Johns Hopkins University undertook a systematic review in 2004. It demonstrated that existing guidelines, including The Integrated Management of Childhood Illness (IMCI), do not cover all priority conditions in emergencies. The objective of this manual is to provide comprehensive guidance on child care in emergencies.
Over the past few decades and throughout the world, the landscape of adolescent health has been altered dramatically. Currently, the total population of adolescents between the ages of 10 and 19 yea...
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
Maintaining proper storage conditions for health commodities is vital to ensuring their quality. Product expiration dates are based on ideal storage conditions and protecting product quality until their expiration date is important for serving custo...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly pass...
A Global Campaign Against Epilepsy Demonstration Project
Emergencies, in spite of their tragic nature and adverse effects on mental health, are unparalleled opportunities to build better mental health systems for all people in need. This ... publication shows how this was done in 10 diverse emergency-affected areas
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
